McKesson Medical-Surgical to Distribute Full TempraMed Portfolio Across North America
MCK•On June 23, 2026, McKesson Medical-Surgical broadened its agreement with TempraMed to distribute TempraMed’s full portfolio, including VIVI Cap and VIVI Epi, across its North American B2B channels. The deal provides McKesson with deep access to non-acute care providers and recurring customers, bolstering its medical-surgical offerings.
1. Expanded Distribution Agreement
On June 23, 2026, McKesson Medical-Surgical expanded its partnership with TempraMed to include the full portfolio of temperature-managed medication solutions. Under this non-exclusive deal, McKesson will distribute VIVI Cap, VIVI Cap Smart, VIVI Epi and VIVI Med across its wide B2B and B2B2C channels.
2. Impact on McKesson's Network
The agreement gives McKesson immediate access to TempraMed’s products through its established sales and distribution network serving physician offices, long-term care facilities, ambulatory surgery centers and home health organizations. This diversification enhances McKesson’s recurring revenue streams and strengthens its position in the non-acute care market segment.
3. Strategic Market Context
The move aligns with broader trends toward decentralized care delivery as more treatments shift outside hospitals. Leveraging McKesson's extensive infrastructure and customer base, the expanded partnership is poised to accelerate adoption of thermal protection solutions and support future commercial growth across North America.
